Indian Emulsifiers
- P/E
- 5.96
Key Fundamentals
SMEChemicals & PetrochemicalsChemicalsPrice-based figures as of · TTM
- ROCE
- 15.20%
- Debt to Equity
- 0.37
- EPS (TTM)
- ₹5.60
- Book Value
- ₹53.60
- Market Cap
- —
- P/E (TTM)
- 5.96
- P/B
- 0.62
- ROE
- 14.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹26.20 Cr
- 52W High
- ₹128.00
- 52W Low
- ₹31.50
- Day Range
- ₹33.30 – ₹34.55
- Volume
- 84,500
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Indian Emulsifiers (this company) | ₹33.35 | 5.96 | ₹125 Cr | 0.62 | 0.00% | 14.20% | 15.20% | ₹32 Cr | ₹5 Cr |
| Median 8 companies | ₹1,559.55 | 43.80 | ₹20,474 Cr | 4.68 | 0.16% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 43
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 52
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 93
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 58
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 4
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 38
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.52 times its book value
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 32.6%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 6 | 1 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 34.63
- Neutral
- MACD (12,26,9)
- −2.62
- Bearish
- SMA (50)
- 42.25
- Bearish
- SMA (200)
- 57.23
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | Zero base |
|---|---|
| 3Y | +57.44% |
| 1Y | +58.42% |
Net profit
| 5Y | Zero base |
|---|---|
| 3Y | +58.74% |
| 1Y | +23.08% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Turned negative |
| 1Y | Outflow widened by ₹11 Cr |
Operating margin· change in pp
| 5Y | No sales |
|---|---|
| 3Y | −3.26 pp |
| 1Y | −3.55 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2021 | ₹0.00 Cr |
|---|---|
| Mar 2022 | ₹18.00 Cr |
| Mar 2023 | ₹41.00 Cr |
| Mar 2024 | ₹67.00 Cr |
| Mar 2025 | ₹101 Cr |
| Mar 2026 | ₹160 Cr |
Net profit by year
| Mar 2021 | ₹0.00 Cr |
|---|---|
| Mar 2022 | ₹0.00 Cr |
| Mar 2023 | ₹4.00 Cr |
| Mar 2024 | ₹9.00 Cr |
| Mar 2025 | ₹13.00 Cr |
| Mar 2026 | ₹16.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 35 | 32 | 52 | 50 | 77 | 83 |
| Expenses | 29 | 23 | 41 | 40 | 62 | 72 |
| Operating Profit | 6 | 8 | 10 | 9 | 15 | 11 |
| OPM % | 19% | 26% | 20% | 19% | 20% | 13% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 |
| PBT | 5 | 6 | 9 | 8 | 12 | 7 |
| Tax % | 18% | 19% | 18% | 20% | 17% | 21% |
| Net Profit | 4 | 5 | 7 | 6 | 10 | 6 |
| EPS (₹) | 4.24 | 3.71 | 3.81 | 3.45 | 5.61 | 3.23 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 0 | 18 | 41 | 67 | 101 | 160 |
| Expenses | 0 | 17 | 33 | 52 | 82 | 134 |
| Operating Profit | 0 | 1 | 8 | 15 | 20 | 26 |
| OPM % | — | 4.5% | 19% | 22% | 19% | 16% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 2 | 2 | 2 | 4 |
| Depreciation | 0 | 0 | 1 | 2 | 2 | 3 |
| PBT | 0 | 0 | 5 | 11 | 16 | 20 |
| Tax % | — | 67% | 16% | 18% | 19% | 18% |
| Net Profit | 0 | 0 | 4 | 9 | 13 | 16 |
| EPS (₹) | — | 0.04 | 4.32 | 6.53 | 7.27 | 8.84 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 6 | 6 | 9 | 12 | 18 |
| Reserves | 0 | 0 | 4 | 19 | 70 | 129 |
| Borrowings | 1 | 13 | 22 | 24 | 26 | 55 |
| Other Liabilities | 0 | 0 | 2 | 12 | 10 | 33 |
| Total Liabilities | 1 | 19 | 34 | 64 | 117 | 235 |
| Fixed Assets | 0 | 10 | 13 | 17 | 19 | 53 |
| CWIP | 0 | 0 | 0 | 3 | 21 | 23 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1 | 9 | 22 | 44 | 77 | 159 |
| Total Assets | 1 | 19 | 34 | 64 | 117 | 235 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | −6 | 0 | 0 | −17 | −28 |
| Investing | 0 | −2 | 0 | −8 | −23 | −39 |
| Financing | 0 | 8 | 0 | 8 | 40 | 75 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 7 |
| Free Cash Flow | 0 | −16 | −4 | −9 | −39 | −66 |
| CFO/EBITDA | — | −720 | 3 | 8 | −74 | −96 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 60 | 71 | 101 | 110 | 131 |
| Inventory Days | — | 32 | 106 | 162 | 185 | 191 |
| Days Payable | — | 0 | 11 | 69 | 33 | 78 |
| Cash Conversion Cycle | — | 92 | 166 | 195 | 263 | 245 |
| Working Capital Days | — | 125 | 97 | 115 | 172 | 201 |
| ROCE % | — | 6% | 26% | 31% | 24% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Indian Emulsifiers insights
59 extracted metrics across FY21–FY26.
Documents
- Concall · Jun 2026Transcript PPT Recording
- Concall · Nov 2025Transcript PPT
- Concall · Oct 2025PPT
- Concall · May 2025Transcript PPT Recording
- 2 Oct 2026
- 30 Sep 2026
- 28 Sep 2026
Frequently Asked Questions about Indian Emulsifiers
What does Indian Emulsifiers Ltd do?
Where is Indian Emulsifiers Ltd (IEML) listed?
Which sector does Indian Emulsifiers Ltd belong to?
What is the PE ratio of Indian Emulsifiers Ltd?
What is the 52-week high and low of Indian Emulsifiers Ltd?
What is the Return on Equity (ROE) of Indian Emulsifiers Ltd?
Company Information
Incorporated in 2020, Indian Emulsifiers Ltd is in the business of Manufacturing and Supplying of Speciality Chemicals
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IEML.md for Indian Emulsifiers Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.